Marie Skłodowska-Curie Actions Postdoctoral Fellowships 2022 at HT
Human Technopole is looking for enthusiastic postdoctoral researchers interested in applying for Marie Skłodowska-Curie Actions Postdoctoral Fellowships 2022.
Projects should focus on one of the areas of the five HT’s Research Centres: Computational Biology, Structural Biology, Genomics, Neurogenomics and Health Data Science.
The objective of PFs is to support researchers’ careers and foster excellence in research. The Postdoctoral Fellowships action targets researchers holding a PhD who wish to carry out their research activities abroad, acquire new skills and develop their careers. PFs help researchers gain experience in other countries, disciplines and non-academic sectors.
The fellowship typically covers the researcher’s salary (living and mobility allowance) for two years, research, training and networking activities costs and overheads for the host institution.
Eligibility criteria
- The researcher must hold a doctoral degree with no more than 8 years of experience after the completion of their PhD
- The researcher can be of any nationality
- The researcher must not have resided or carried out his/her main activity (work, studies, etc.) in Italy for more than twelve months in the three years immediately prior to the call deadline
How to apply
Please apply, indicating the Research Group of interest, by sending your CV and a brief outline of the proposed research project describing how it synergizes with the Research Centre and Group (1 page maximum) to MSCA@fht.org by June 30th 2022.
Potential candidates will be internally pre-selected and notified of the outcome of their application by July 15th 2022, in order to proceed with the official MSCA-PF application (deadline September 14th 2022). Selected applicants will develop their MSCA-PF proposal in cooperation with the proposed supervisor.
Benefits
- A living allowance
- A mobility allowance
- If applicable, family, long-term leave, and special needs allowances
- Funding for research, training, and networking activities
- Management and indirect costs (to the host institution)
For more details on the research areas of interest visit Euraxess
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.